Jonas Halfvarson is a Cross Autoimmunity Prevention Symposium Attendee

Dr. Halfvarson is a gastroenterologist whose research defines the genetic and immunologic mechanisms driving inflammatory bowel disease (IBD) with a focus on biomarker discovery in the preclinical disease phase. By advancing research in the preclinical phase of IBD, he is enabling earlier detection, refined risk stratification, and precision prevention strategies aimed at intercepting immune-mediated gut inflammation before irreversible damage occurs.